Shanghai HeartCare Medical Technology Corporation Limited (HKG:6609)

Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
43.80
+2.10 (5.04%)
Mar 10, 2026, 2:31 PM HKT
58.12%
Market Cap 1.58B
Revenue (ttm) 367.02M
Net Income (ttm) 46.50M
Shares Out 37.86M
EPS (ttm) 1.22
PE Ratio 34.12
Forward PE 38.36
Dividend n/a
Ex-Dividend Date n/a
Volume 171,350
Average Volume 34,338
Open 41.68
Previous Close 41.70
Day's Range 41.68 - 43.98
52-Week Range 24.30 - 71.25
Beta 0.66
RSI 31.20
Earnings Date Mar 25, 2026

About HKG:6609

Shanghai HeartCare Medical Technology Corporation Limited engages in the research and development, manufacture, and sale of neuro-interventional medical devices in Mainland China and internationally. It offers ischemic stroke thrombectomy devices, such as Captor Thrombectomy Stent, a thrombectomy stent retriever; aspiration catheter and pump; intracranial stenosis treatment devices, including intracranial drug-eluting balloon stent, embolization protection system, carotid artery stent, and intracranial balloon dilatation catheter and carotid ar... [Read more]

Industry Medical Devices
Sector Healthcare
Founded 2016
Employees 327
Stock Exchange Hong Kong Stock Exchange
Ticker Symbol 6609
Full Company Profile

Financial Performance

In 2024, HKG:6609's revenue was 277.90 million, an increase of 19.61% compared to the previous year's 232.34 million. Losses were -13.62 million, -85.51% less than in 2023.

Financial numbers in CNY Financial Statements

News

There is no news available yet.